# This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)

> **NCT02859909** · PHASE3 · COMPLETED · sponsor: **Biotest** · enrollment: 34 (actual)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **BIOLOGICAL:** BT595

## Key facts

- **NCT ID:** NCT02859909
- **Lead sponsor:** Biotest
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02859909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02859909, "This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02859909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*